Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pernille Kølbæk, Oskar Hougaard Jefsen, Maria Speed & Søren Dinesen Østergaard. (2022) Mental health of patients with mental illness during the COVID-19 pandemic lockdown: a questionnaire-based survey weighted for attrition. Nordic Journal of Psychiatry 76:5, pages 338-347.
Read now
Read now
Pernille Kølbæk, Daniel Guinart, Mark Opler, Christoph U. Correll, Ole Mors & Søren D. Østergaard. (2021) Clinical validation of the Symptom Self-rating Scale for Schizophrenia (4S) among inpatients. Nordic Journal of Psychiatry 75:6, pages 454-464.
Read now
Read now
Articles from other publishers (10)
Berta Moreno‐Küstner, Julia Fábrega‐Ruz, Juan Luis Gonzalez‐Caballero, Sara Reyes‐Martin, Susana Ochoa, Cristina Romero‐Lopez‐Alberca, Jordi Cid, Regina Vila‐Badia, Eva Frigola‐Capell & Luis Salvador‐Carulla. (2022) Patient‐reported impact of symptoms in schizophrenia scale (PRISS): Development and validation. Acta Psychiatrica Scandinavica 145:6, pages 640-655.
Crossref
Crossref
Warut Aunjitsakul, Teerapat Teetharatkul, Arnont Vitayanont & Tippawan Liabsuetrakul. (2021) Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?. Administration and Policy in Mental Health and Mental Health Services Research 48:5, pages 768-779.
Crossref
Crossref
Norman Jay Stomski, Paul Morrison & Amanda Meyer. (2015) Antipsychotic medication side effect assessment tools: A systematic review. Australian & New Zealand Journal of Psychiatry 50:5, pages 399-409.
Crossref
Crossref
Jacqueline N. Kiwanuka, Gregory P. Strauss, Robert P. McMahon & James M. Gold. (2014) Psychological predictors of functional outcome in people with schizophrenia. Schizophrenia Research 157:1-3, pages 299-304.
Crossref
Crossref
Sigrid Stjernswärd, Karin Persson, René Nielsen, Eva Tuninger & Sten Levander. (2013) A modified Drug Attitude Inventory used in long-term patients in sheltered housing. European Neuropsychopharmacology 23:10, pages 1296-1299.
Crossref
Crossref
Fraser Anderson & Daniel Freeman. (2013) Socioeconomic Status and Paranoia. Journal of Nervous & Mental Disease 201:8, pages 698-702.
Crossref
Crossref
Shaunna L. Clark, Renan P. Souza, Daniel E. Adkins, Karolina Åberg, József Bukszár, Joseph L. McClay, Patrick F. Sullivan & Edwin J.C.G. van den Oord. (2013) Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment. Pharmacogenetics and Genomics 23:2, pages 69-77.
Crossref
Crossref
D. Freeman, S. McManus, T. Brugha, H. Meltzer, R. Jenkins & P. Bebbington. (2010) Concomitants of paranoia in the general population. Psychological Medicine 41:5, pages 923-936.
Crossref
Crossref
Bo Ivarsson, Leif Lindström, Ulf Malm & Torsten Norlander. (2011) The Self-Assessment Perceived Global Distress Scale-Reliability and Construct Validity—Perceived Global Distress Scale. Psychology 02:04, pages 283-290.
Crossref
Crossref
Bo Ivarsson, Leif Lindström, Ulf Malm & Torsten Norlander. (2011) Consumer satisfaction, quality of life and distress with regard to social function and gender in severe mental illness. Open Journal of Psychiatry 01:03, pages 88-97.
Crossref
Crossref